Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
SARS-CoV-2
variants of concern
vaccines
original antigenic sin
heterotypic boost
passive immunization
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791

Documents similaires